4,546
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction

, , , , , , , , , , , , & show all
Article: 2295429 | Received 20 Jul 2023, Accepted 12 Dec 2023, Published online: 28 Dec 2023

References

  • Anderson GL, Limacher M. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the women’s health initiative randomized controlled trial. J Am Med Assoc. 2004;291:1701–19.
  • Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women. JAMA. 2004;291(24):2947–58. doi:10.1001/jama.291.24.2947.
  • Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. J Am Med Assoc. 2007;297(13):1465–1477. doi:10.1001/jama.297.13.1465.
  • Magnusson C, Baron JA, Correia N, Bergström R, Adami HO, Persson I. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer. 1999;81(3):339–44. doi:10.1002/(SICI)1097-0215(19990505)81:3<339:AID-IJC5>3.0.CO;2-6.
  • Grodstein F, Manson JE, Stampfer MJ. Postmenopausal hormone use and secondary prevention of coronary events in the nurses’ health study: a prospective, observational study. Ann Intern Med. 2001;135(1):1. doi:10.7326/0003-4819-135-1-200107030-00003.
  • Markle JGM, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Sci. 2013;339(6123):1084–1088. doi:10.1126/science.1233521.
  • Santos-Marcos JA, Rangel-Zuñiga OA, Jimenez-Lucena R, Quintana-Navarro GM, Garcia-Carpintero S, Malagon MM, Landa BB, Tena-Sempere M, Perez-Martinez P, Lopez-Miranda J, et al. Influence of gender and menopausal status on gut microbiota. Maturitas. 2018;116:43–53. doi:10.1016/j.maturitas.2018.07.008.
  • Shin JH, Park YH, Sim M, Kim SA, Joung H, Shin DM. Serum level of sex steroid hormone is associated with diversity and profiles of human gut microbiome. Res Microbiol. 2019;170(4–5):192–201. doi:10.1016/j.resmic.2019.03.003.
  • Wu JM, Zhuo YY, Liu YL, Chen Y, Ning Y, Yao JL. Association between premature ovarian insufficiency and gut microbiota. BMC Pregnancy Child. 2021;21(1):21. doi:10.1186/s12884-021-03855-w.
  • Holert J, Cardenas E, Bergstrand LH, Zaikova E, Hahn AS, Hallam SJ, Mohn WW. Metagenomes reveal global distribution of bacterial steroid catabolism in natural, engineered, and host environments. mBio. 2018;9(1). doi:10.1128/mBio.02345-17.
  • Levitz M, Katz J. Enterohepatic metabolism of Estriol-3-sulfate-16-glucosiduronate in women 1. J Clin Endocr Metab. 1968;28(6):862–868. doi:10.1210/jcem-28-6-862.
  • Stoa KF, Levitz M. Comparison of the conjugated metabolites of intravenously and intraduodenally administered oestriol. Acta Endocrinol (Copenh). 1968;57(4):657–668. doi:10.1530/acta.0.0570657.
  • Järvenpää P, Kosunen T, Fotsis T, Adlercreutz H. In vitro metabolism of estrogens by isolated intestinal micro-organisms and by human faecal microflora. J Steroid Biochem. 1980;13(3):345–349. doi:10.1016/0022-4731(80)90014-X.
  • Wang PH, Chen YL, Wei ST, Wu K, Lee TH, Wu TY, Chiang YR. Retroconversion of estrogens into androgens by bacteria via a cobalamin-mediated methylation. Proc Natl Acad Sci U S A. 2020;117(3):1395–403. doi:10.1073/pnas.1914380117.
  • Li D, Sun T, Tong Y, Le J, Yao Q, Tao J, Liu H, Jiao W, Mei Y, Chen J, et al. Gut-microbiome-expressed 3β-hydroxysteroid dehydrogenase degrades estradiol and is linked to depression in premenopausal females. Cell Metab. 2023;35(4):685–694.e5. doi:10.1016/j.cmet.2023.02.017.
  • Org E, Mehrabian M, Parks BW, Shipkova P, Liu X, Drake TA, Lusis AJ. Sex differences and hormonal effects on gut microbiota composition in mice. Gut Microbes. 2016;7(4):313–22. doi:10.1080/19490976.2016.1203502.
  • Park S, Kim DS, Kang ES, Kim DB, Kang S. Low-dose brain estrogen prevents menopausal syndrome while maintaining the diversity of the gut microbiomes in estrogen-deficient rats. Am J Physiol-Endoc M. 2018;315(1):E99–E109. doi:10.1152/ajpendo.00005.2018.
  • Moreno-Indias I, Sánchez-Alcoholado L, Sánchez-Garrido MÁ, Martín-Núñez GM, Pérez-Jiménez F, Tena-Sempere M, Tinahones FJ, Queipo-Ortuño MI. Neonatal androgen exposure causes persistent gut microbiota dysbiosis related to metabolic disease in adult female rats. Endocrinol. 2016;157(12):4888–98. doi:10.1210/en.2016-1317.
  • Cross T-W, Zidon TM, Welly RJ, Park YM, Britton SL, Koch LG, Rottinghaus GE, de Godoy MRC, Padilla J, Swanson KS, et al. Soy improves cardiometabolic health and cecal microbiota in female low-fit rats. Sci Rep. 2017;7(1):9261. doi:10.1038/s41598-017-08965-0.
  • Sau L, Olmstead CM, Cui LJ, Chen A, Shah RS, Kelley ST, Thackray VG. Alterations in gut microbiota do not play a causal role in diet-independent weight gain caused by ovariectomy. J Endocr Soc. 2021;5(1):1–11. doi:10.1210/jendso/bvaa173.
  • Choi S, Hwang YJ, Shin MJ, Yi H. Difference in the gut microbiome between ovariectomy-induced obesity and diet-induced obesity. J Microbiol Biotechnol. 2017;27(12):2228–36. doi:10.4014/jmb.1710.10001.
  • Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–1772. doi:10.2337/db06-1491.
  • Novitsky TJ. Limitations of the limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann N Y Acad Sci. 1998;851(1):416–421. doi:10.1111/j.1749-6632.1998.tb09018.x.
  • Citronberg JS, Wilkens LR, Lim U, Hullar MA, White E, Newcomb PA, Le Marchand L, Lampe JW. Reliability of plasma lipopolysaccharide-binding protein (LBP) from repeated measures in healthy adults. Cancer Causes Control. 2016;27(9):1163–6. doi:10.1007/s10552-016-0783-9.
  • Cani PD, Bibiloni R, Knauf C, Waget AM, Neyrinck AM, Delzenne NM, Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice. Diabetes. 2008;57(6):1470–81. doi:10.2337/db07-1403.
  • Lassenius MI, Pietilainen KH, Kaartinen K, Pussinen PJ, Syrjanen J, Forsblom C, Pörsti I, Rissanen A, Kaprio J, Mustonen J, et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diab Care. 2011;34(8):1809–1815. doi:10.2337/dc10-2197.
  • Rojo ÓP, San Roman AL, Arbizu EA, Martinez AD, Sevillano ER, Martinez AA. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13(3):269–77. doi:10.1002/ibd.20019.
  • Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444(7122):1022–1023. doi:10.1038/4441022a.
  • Ito T, Kubo M, Nagaoka K, Funakubo N, Setiawan H, Takemoto K, Eguchi E, Fujikura Y, Ogino K. Early obesity leads to increases in hepatic arginase I and related systemic changes in nitric oxide and l-arginine metabolism in mice. J Physiol Biochem. 2018;74(1):9–16. doi:10.1007/s13105-017-0597-6.
  • Santos-Marcos JA, Rangel-Zuniga OA, Jimenez-Lucena R, Quintana-Navarro GM, Garcia-Carpintero S, Malagon MM, Landa BB, Tena-Sempere M, Perez-Martinez P, Lopez-Miranda J, et al. Influence of gender and menopausal status on gut microbiota. Maturitas. 2018;116:43–53. doi:10.1016/j.maturitas.2018.07.008.
  • Peters BA, Lin J, Qi Q, Usyk M, Isasi CR, Mossavar-Rahmani Y, Derby CA, Santoro N, Perreira KM, Daviglus ML, et al. Menopause is associated with an altered gut microbiome and estrobolome, with implications for adverse cardiometabolic risk in the hispanic community health study/study of latinos. mSystems. 2022;7(3):e0027322. doi:10.1128/msystems.00273-22.
  • Mayneris-Perxachs J, Arnoriaga-Rodriguez M, Luque-Cordoba D, Priego-Capote F, Perez-Brocal V, Moya A, Burokas A, Maldonado R, Fernández-Real JM. Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status. Microbiome. 2020;8(1):8. doi:10.1186/s40168-020-00913-x.
  • Cox-York KA, Sheflin AM, Foster MT, Gentile CL, Kahl A, Koch LG, Britton SL, Weir TL. Ovariectomy results in differential shifts in gut microbiota in low versus high aerobic capacity rats. Physiol Rep. 2015;3(8):1–14. doi:10.14814/phy2.12488.
  • Van Der Giessen J, Van Der Woude CJ, Peppelenbosch MP, Fuhler GM. A direct effect of sex hormones on epithelial barrier function in inflammatory bowel disease models. Cells. 2019;8(3):261. doi:10.3390/cells8030261.
  • Xiao X, Liu D, Zheng S, Fu J, Zhang H, Chen L. Protective effect of estrogen on intestinal ischemia-reperfusion injury in pubertal rats. J Pediatr Surg. 2004;39(12):1828–1831. doi:10.1016/j.jpedsurg.2004.08.028.
  • Chen TS, Doong ML, Chang FY, Lee SD, Wang PS. Effects of sex steroid hormones on gastric emptying and gastrointestinal transit in rats. Am J Physiol-Gastr L. 1995;268(1):G171–G176. doi:10.1152/ajpgi.1995.268.1.G171.
  • Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi:10.1038/nature05414.
  • Ervin SM, Li H, Lim L, Roberts LR, Liang X, Mani S, Redinbo MR. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem. 2019;294(49):18586–18599. doi:10.1074/jbc.RA119.010950.
  • Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, Gajer P, Ravel J, Goedert JJ. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med. 2012;10(1):253. doi:10.1186/1479-5876-10-253.
  • Mahdi A, Kövamees O, Pernow J. Improvement in endothelial function in cardiovascular disease - is arginase the target? Int J Cardiol. 2020;301:207–214.
  • Davis NM, Lissner MM, Richards CL, Chevée V, Gupta AS, Gherardini FC, Schneider DS. Metabolomic analysis of diverse mice reveals hepatic arginase-1 as source of plasma arginase in plasmodium chabaudi infection. mBio. 2021;12(5). doi:10.1128/mBio.02424-21.
  • Pernow J, Jung C. Arginase as apotential target in the treatment of cardiovascular disease: reversal of arginine steal?Cardiovasc Res. 2013;98(3):334–343.
  • Abebe EC, Muche ZT, Mariam ABT, Ayele T, Agidew MM, Azezew MT, Abebe Zewde E, Asmamaw Dejenie T, Asmamaw Mengstie M. The structure, biosynthesis, and biological roles of Fetuin-A: a review. Front Cell Dev Biol. 2022;10:10. doi:10.3389/fcell.2022.945287.
  • Jahnen-Dechent W, Heiss A, Schäfer C, Ketteler M, Towler DA. Fetuin-A regulation of calcified matrix metabolism. Circ Res. 2011;108(12):1494–1509. doi:10.1161/CIRCRESAHA.110.234260.
  • Brix JM, Stingl H, Hollerl F, Schernthaner GH, Kopp HP, Schernthaner G. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab. 2010;95(11):4877–4881. doi:10.1210/jc.2010-0148.
  • Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A, Cauley JA, Harris TB, Cummings SR, Shlipak MG. Fetuin-A and incident diabetes mellitus in older persons. JAMA. 2008;300(2):182–188. doi:10.1001/jama.300.2.182.
  • Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. J Clin Endocrinol Metab. 2012;97(12):4717–4723. doi:10.1210/jc.2012-2414.
  • Seyithanoğlu M, Öner-Iyidoğan Y, Doğru-Abbasoğlu S, Tanrikulu-Küçük S, Kocąk H, Beyhan-Özdaş Ş, Koçak-Toker N. The effect of dietary curcumin and capsaicin on hepatic fetuin-A expression and fat accumulation in rats fed on a high-fat diet. Arch Physiol Biochem. 2016;122(2):94–102. doi:10.3109/13813455.2015.1120753.
  • Öner-İ̇yidoğan Y, Koçak H, Seyidhanoğlu M, Gürdöl F, Gülçubuk A, Yildirim F, Çevik A, Uysal M. Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet. J Physiol Biochem. 2013;69(4):677–686. doi:10.1007/s13105-013-0244-9.
  • Shen X, Yang L, Yan S, Zheng H, Liang L, Cai X, Liao M. Fetuin a promotes lipotoxicity in β cells through the TLR4 signaling pathway and the role of pioglitazone in anti-lipotoxicity. Mol Cell Endocrinol. 2015;412:1–11. doi:10.1016/j.mce.2015.05.014.
  • Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, Ray S, Majumdar SS, Bhattacharya S. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 2012;18(8):1279–1285. doi:10.1038/nm.2851.
  • Khalili L, Alipour B, Jafar-Abadi MA, Faraji I, Hassanalilou T, Abbasi MM, Vaghef-Mehrabany E, Alizadeh Sani M. The effects of lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-A levels in patients with type 2 diabetes mellitus: a randomized controlled trial. Iran Biomed J. 2019;23(1):68–77. doi:10.29252/ibj.23.1.68.
  • Mularczyk M, Bourebaba Y, Kowalczuk A, Marycz K, Bourebaba L. Probiotics-rich emulsion improves insulin signalling in palmitate/oleate-challenged human hepatocarcinoma cells through the modulation of fetuin-A/TLR4-JNK-NF-κB pathway. Biomed Pharmacother. 2021;139:111560\. doi:10.1016/j.biopha.2021.111560.
  • Thyfault JP, Rector RS, Uptergrove GM, Borengasser SJ, Morris EM, Wei Y, Laye MJ, Burant CF, Qi NR, Ridenhour SE, et al. Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury. J Physiol. 2009;587(8):1805–1816. doi:10.1113/jphysiol.2009.169060.
  • Smith SD, Cardona MA, Wishnev SA, Kurkchubasche AG, Rowe MI. Unique characteristics of the neonatal intestinal mucosal barrier. J Pediatr Surg. 1992;27(3):333–338. doi:10.1016/0022-3468(92)90857-4.
  • Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, Owens SM, Betley J, Fraser L, Bauer M, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J. 2012;6(8):1621–1624. doi:10.1038/ismej.2012.8.
  • Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–857. doi:10.1038/s41587-019-0209-9.
  • Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–583. doi:10.1038/nmeth.3869.
  • McDonald D, Price MN, Goodrich J, Nawrocki EP, Desantis TZ, Probst A, Andersen GL, Knight R, Hugenholtz P. An improved greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6(3):610–618. doi:10.1038/ismej.2011.139.
  • Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E, Knight R, Huttley GA, Gregory Caporaso J. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin. Microbiome. 2018;6(1)90. doi:10.1186/s40168-018-0470-z.
  • Malinen E, Rinttila T, Kajander K, Matto J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005;100(2):373–1249. doi:10.1111/j.1572-0241.2005.40312.x.
  • Suchodolski JS, Markel ME, Garcia-Mazcorro JF, Unterer S, Heilmann RM, Dowd SE, Kachroo P, Ivanov I, Minamoto Y, Dillman EM, et al. The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease. PLoS ONE. 2012;7(12):e51907. doi:10.1371/journal.pone.0051907.
  • Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, Venkatesh M, Jobin C, Yeh LA, Mani S, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 2010;330(6005):831–835. doi:10.1126/science.1191175.
  • Wallace BD, Roberts AB, Pollet RM, Ingle JD, Biernat KA, Pellock SJ, Venkatesh M, Guthrie L, O’Neal S, Robinson S, et al. Structure and inhibition of microbiome β-glucuronidases essential to the alleviation of cancer drug toxicity. Chem Biol. 2015;22(9):1238–1249. doi:10.1016/j.chembiol.2015.08.005.
  • McMurdie PJ, Holmes S, Watson M. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE. 2013;8(4):e61217. doi:10.1371/journal.pone.0061217.
  • Lin H, Peddada SD. Analysis of compositions of microbiomes with bias correction. Nat Commun. 2020;11(1):3514. doi:10.1038/s41467-020-17041-7.